156 related articles for article (PubMed ID: 36166208)
1. Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States.
Huepenbecker SP; Sun CC; Fu S; Zhao H; Primm K; Rauh-Hain JA; Fleming ND; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2022 Sep; 32(9):1153-1163. PubMed ID: 36166208
[TBL] [Abstract][Full Text] [Related]
2. Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.
Huepenbecker SP; Sun CC; Fu S; Zhao H; Primm K; Giordano SH; Meyer LA
Cancer; 2021 Nov; 127(22):4151-4160. PubMed ID: 34347287
[TBL] [Abstract][Full Text] [Related]
3. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities in the treatment of advanced epithelial ovarian cancer.
Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
[TBL] [Abstract][Full Text] [Related]
5. Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist Consultation.
Gupta A; Chen Q; Wilson LE; Huang B; Pisu M; Liang M; Previs RA; Moss HA; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
JAMA Netw Open; 2023 Feb; 6(2):e2254595. PubMed ID: 36723938
[TBL] [Abstract][Full Text] [Related]
6. Health Care Utilization Prior to Ovarian Cancer Diagnosis in Publicly Insured Individuals in New York State.
Gates Kuliszewski M; Boscoe FP; Wagner VL; Schymura MJ
J Registry Manag; 2021; 48(3):126-137. PubMed ID: 35413730
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States.
Huepenbecker SP; Sun CC; Fu S; Zhao H; He W; Primm K; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2022 Jul; 32(7):899-905. PubMed ID: 35331992
[TBL] [Abstract][Full Text] [Related]
8. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
9. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
Vogel TJ; Goodman MT; Li AJ; Jeon CY
Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer outcomes: Predictors of early death.
Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA
Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531
[TBL] [Abstract][Full Text] [Related]
11. Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis.
Albright BB; Nasioudis D; Craig S; Moss HA; Latif NA; Ko EM; Haggerty AF
Am J Obstet Gynecol; 2021 Feb; 224(2):195.e1-195.e17. PubMed ID: 32777264
[TBL] [Abstract][Full Text] [Related]
12. Survival disparities among racial/ethnic groups of women with ovarian cancer: An update on data from the Surveillance, Epidemiology and End Results (SEER) registry.
Stenzel AE; Buas MF; Moysich KB
Cancer Epidemiol; 2019 Oct; 62():101580. PubMed ID: 31400533
[TBL] [Abstract][Full Text] [Related]
13. Association of guideline-concordant care with survival, health care utilization, and costs among older women with advanced epithelial ovarian cancer.
Kamat S; Brown BR; Hume A; Vyas A
Am J Manag Care; 2023 Oct; 29(10):e292-e298. PubMed ID: 37870550
[TBL] [Abstract][Full Text] [Related]
14. Racial Differences in Survival From Epithelial Ovarian Cancer Are Associated With Stage at Diagnosis and Use of Neoadjuvant Therapy: A 10-Year Single-Institution Experience With a Racially Diverse Urban Population.
Miller EM; Tymon-Rosario J; Strickler HD; Xie X; Xue X; Kuo DYS; Makhija SK; Nevadunsky NS
Int J Gynecol Cancer; 2018 May; 28(4):749-756. PubMed ID: 29538252
[TBL] [Abstract][Full Text] [Related]
15. Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study.
Montes de Oca MK; Wilson LE; Previs RA; Gupta A; Joshi A; Huang B; Pisu M; Liang M; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
J Natl Compr Canc Netw; 2022 Nov; 20(11):1255-1266.e11. PubMed ID: 36351338
[TBL] [Abstract][Full Text] [Related]
16. Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian Cancer.
Akinyemiju TF; Wilson LE; Diaz N; Gupta A; Huang B; Pisu M; Deveaux A; Liang M; Previs RA; Moss HA; Joshi A; Ward KC; Schymura MJ; Berchuck A; Potosky AL
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1383-1393. PubMed ID: 35477150
[TBL] [Abstract][Full Text] [Related]
17. Fertility preservation and survival among young women with early ovarian cancer living in US counties with gynecologic oncologist services.
Hillman RT; Saenz CC; McHale MT; Plaxe SC
Int J Gynaecol Obstet; 2017 May; 137(2):157-163. PubMed ID: 28170079
[TBL] [Abstract][Full Text] [Related]
18. Disparities in treatment and survival among elderly ovarian cancer patients.
Taylor JS; He W; Harrison R; Zhao H; Sun CC; Lu KH; Giordano SH; Meyer LA
Gynecol Oncol; 2018 Nov; 151(2):269-274. PubMed ID: 30253875
[TBL] [Abstract][Full Text] [Related]
19. Racial Disparities in Survival Outcomes of Patients With Serous Epithelial Ovarian Cancer: A Retrospective Cohort Analysis.
Shingala K; Stavros S; Parag S; Tercek A; Makhani SS; Bouz A; Galbo A; Chung-Bridges K
Cureus; 2023 Jan; 15(1):e34389. PubMed ID: 36874646
[TBL] [Abstract][Full Text] [Related]
20. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
